• Report Adverse Event or Product Quality Complaint
  • US Site
  • Global Site
AstraZeneca Medical Information
  • Therapy Areas
    • All Therapeutic Areas
    • Cardiovascular
    • Immunology
    • Infection
    • Metabolic
    • Oncology
    • Renal
    • Respiratory
    • Rare Disease (Alexion)
  • Medications
  • Resources
    • Congress Library
    • Disease Education
    • Pipeline
    • Clinical Trials
    • Open innovation
    • Access 360
    • Affordability Programs
    • Sample Closet
    • Medical Education Grant
    • Rare Disease (Alexion)
  • Connect
    • Find an MSL
    • Request an MSL
    • Submit an MIR
    • Give Feedback
User
  • Login to My AZmedical
  • Register for My AZmedical

Search Medical Information

Respiratory

AstraZeneca is pleased to present healthcare professionals with a variety of respiratory resources for your informational purposes. The educational materials are intended to provide information that can assist you in forming your own clinical and treatment decisions.

  1. Congress Library
  2. Medications
  3. Disease Education
  4. Continuing Education
  5. Pipeline

pipeline

This page provides access to AstraZeneca presentations and posters shared during the congresses listed below. Content availability is subject to the timeliness and permissions outlined by respective congresses.

ACAAI 2025

American College of Allergy, Asthma & Immunology

 

November 6 - 10, 2025

Visit website

 

 

CHEST 2025

American College of Chest Physicians (ACCP) - CHEST Annual Meeting

 

October 19 - 22, 2025

Visit website

 

 

ERS 2025

European Respiratory Society (ERS) – 35th Annual Congress

 

September 27 - October 1, 2025

Visit website

 

 

ERhS 2025

European Rhinologic Society

 

June 22 - 25, 2025

Visit website

 

 

EAACI 2025

European Academy of Allergy and Clinical Immunology

 

June 14 - 16, 2025

Visit website

 

 

ATS 2025

American Thoracic Society

 

May 16 - 21, 2025

Visit website

 

 

AAAAI 2025

American Academy of Allergy, Asthma & Immunology

 

February 28 – March 3, 2025

Visit website

 

 

  • AIRSUPRA<sup>®</sup> (albuterol and budesonide) inhalation aerosol
  • BEVESPI AEROSPHERE<sup>®</sup> (glycopyrrolate and formoterol fumarate) inhalation aerosol
  • BREZTRI AEROSPHERE<sup>®</sup> (budesonide, glycopyrrolate, and formoterol fumarate) inhalation aerosol
  • DALIRESP<sup>®</sup> (roflumilast) Tablets
  • FASENRA<sup>®</sup> (benralizumab) injection, for subcutaneous use
  • PULMICORT RESPULES<sup>®</sup> (budesonide inhalation suspension)
  • SYMBICORT<sup>®</sup> Spanish
  • SYMBICORT<sup>®</sup> (budesonide/formoterol fumarate dihydrate) Inhalation Aerosol
  • TEZSPIRE<sup>®</sup> (tezepelumab-ekko) Injection, for subcutaneous use
  • Asthma Explore Asthma
  • Chronic Obstructive Pulmonary Disease Explore Chronic Obstructive Pulmonary Disease
  • Chronic Rhinosinusitis with Nasal Polyps Explore Chronic Rhinosinusitis with Nasal Polyps
  • EGPA Explore EGPA
  • Eosinophilic Granulomatosis with Polyangiitis (EGPA) Explore Eosinophilic Granulomatosis with Polyangiitis (EGPA)
  • IC Configuration editor Explore IC Configuration editor
  • IC Configuration editor Explore IC Configuration editor

e-learning

MPA, GPA, and EGPA: What Pulmonologists Need to Know

American College of Chest Physicians

21-Dec-2024 to 20-Nov-2025

This activity will provide pulmonologists—who serve as sentinel members of the multidisciplinary AAV management team—with a data-driven appraisal of new therapies, as well as established and emerging placement of these new therapies.

Learn More

e-Learning

Updates on Chronic Rhinosinusitis With Nasal Polyps: Uncovering Epithelial Targets in the Upper Airways

Integritas Communications

22-Nov-2024 to 22-Nov-2025

1-hour enduring activity

Learn More

e-Learning

Interleukin-33 and Lower Tract Respiratory Diseases Moving From Pathophysiology to Management

Integritas Communications

23-Jun-2025 to 23-Jun-2026

Join experts Dr. Jonathan Hand, Prof. Dave Singh, and Prof. Tom Wilkinson as they discuss IL-33’s role in respiratory disease, its signaling pathways, therapeutic potential, and current clinical trials targeting IL-33-driven inflammation.

Learn More

e-Learning

The GOLD International COPD Conference (on-demand confernece)

Integrity Continuing Education, Inc.

20-Dec-2024 to 20-Dec-2025

on-demand conference based off of sessions November 11 & 12.

Learn More

e-learning

Ask the Expert: Unraveling the Complexities of Eosinophilic Granulomatosis With Polyangiitis

PRIME Education, LLC

30-Dec-2024 to 29-Dec-2025

1.0-Hour Multi-Accredited On-Demand Webcast (includes Downloadable Patient Tool)

Learn More

e-learning

Stories Behind the Science in EGPA: Updated Strategies for Diagnosis, Treatment, and Reducing the Steroid Burden in Patients

PVI, PeerView Institute for Medical Education, Inc.

28-Feb-2025 to 27-Mar-2026

An on-demand enduring activity based on a recent live event, featuring expert faculty discussing the challenges of recognizing, diagnosing, and managing EGPA.

Learn More

e-Learning

Vasculitis 2025: Advances and Controversies

THE CLEVELAND CLINIC EDUCATIONAL FOUNDATION

10-Jul-2025 to 09-Jul-2027

This comprehensive education dives into the complexities and innovations in the treatment and diagnosis of various forms of vasculitis. 

Learn More

e-Learning

Rethinking CRSwNP: A Comprehensive Learning Experience for Optimized Patient Care

National Jewish Health

30-Jun-2025 to 30-Jun-2026

-Interactive infographic part of a three-part series

-Learners will review the definition and clinical features of CRSwNP, explore inflammatory pathways in a self-paced animation, and review management strategies and current and emerging therapies.

Learn More

e-Learning

Clinical Strategies for Severe Asthma and Chronic Inflammatory Airway Diseases

National Jewish Health

27-Nov-2024 to 27-Nov-2025

This educational program will bring together expert pulmonologists and allergists to discuss the complex and interconnected relationship between severe asthma and upper airway disease.

Learn More

e-Learning

Managing Upper and Lower Airway Diseases: The Role of Epithelial-Driven Inflammation

National Jewish Health

30-Jun-2025 to 30-Jun-2026

-1.5 online enduring activity

 

-Expert faculty from pulmonology, allergy, and otolaryngology explore the complexities of epithelial-driven inflammatory airway diseases.

 

-Clinical case scenarios

Learn More

e-Learning

Interactive On demand activity

Integrity Continuing Education, Inc.

10-Dec-2024 to 11-Dec-2025

An interactive, on-demand activity based on the live program content and video recorded from the live program utilizing the Articulate Storyline platform

Learn More

e-Learning

Clinical Remission in Asthma: An Expert Consensus on the Current Criteria, Evidence, and Impact

National Jewish Health

29-Sep-2025 to 29-Sep-2026

Journal-based CME activity based on an article supplement from a panel of experts presenting the panel's definition of asthma remission and unresolved issues for further investigation.

Learn More

e-Learning

In Conversation: Multidisciplinary Perspectives on Chronic Airways Disease

National Jewish Health

19-Oct-2025 to 19-Oct-2025

Join National Jewish Health for a symposium where top pulmonologists and allergists explore new insights on chronic inflammatory airway diseases. Gain updates on treatment advances, immune cell roles, and strategies for managing airway conditions.

Learn More

e-Learning

Innovating Care for Chronic Respiratory Diseases: Targeting IL-33 and Epithelial Alarmins

National Jewish Health

20-Oct-2025 to 20-Oct-2025

This National Jewish Health program will explore IL-33 and epithelial alarmins in asthma, COPD, and viral infections. Faculty from multiple fields, will engage audiences through frontline perspectives and incorporate cases into their discussions.

Learn More

e-Learning

Web Transforming Asthma Management: The Role of Pharmacists in Implementing Combination Therapy

Postgraduate Healthcare Education, LLC

31-Mar-2025 to 31-Mar-2026

Monograph

Learn More

e-Learning

Tackling CRSwNP Management With Emerging Biologic Therapies Targeting Epithelial Cytokines: Game On!

PVI, PeerView Institute for Medical Education, Inc.

12-Dec-2025 to 12-Dec-2025

Interactive educational event held in conjunction with AAO-HNSF 2025 and focused on the role of epithelial cytokines in CRSwNP and the optimal use of biologic agents.

Learn More

e-Learning

Uncovering the Role of Epithelial Cytokines in CRSwNP: Examining the Clinical Implications of New Approaches With Targeted Biologic Therapy

PVI, PeerView Institute for Medical Education, Inc.

30-Oct-2024 to 29-Oct-2025

1.0 credit hour learner-interactive online enduring activity & point-of-care practice tools

Learn More

e-Learning

(Virtual Live #3 + ME Replay) Striving for Patient Satisfaction in the Present and Future: Personalizing Treatment in an Evolving Paradigm

Answers in CME Inc.

21-Nov-2025 to 12-Dec-2025

Presentation and discussion, led by expert panel, with Q&A opportunity + Recording of virtual live event

Learn More

e-Learning

(Virtual Live #2 + ME Replay) Spotlight on Emerging Biologics: Interpreting the Latest Efficacy and Safety Signals

Answers in CME Inc.

12-Nov-2025 to 12-Dec-2025

Presentation and discussion, led by expert panel, with Q&A opportunity + Recording of virtual live event

Learn More

e-Learning

(Virtual Live #1 + ME Replay) Advances in CRSwNP: Rethinking Biologics and Inflammation at the Source

Answers in CME Inc.

5-Nov-2025 to 12-Dec-2025

Presentation and discussion, led by expert panel, with Q&A opportunity + Recording of virtual live event

Learn More

Email Recipient

Request a field medical follow-up

Welcome to AstraZeneca
Medical Information

The information provided on this site is intended for use by healthcare professionals practicing in the US. The dissemination of this information may be subject to different medical and regulatory requirements in other countries.

This web site is intended to help healthcare professionals practicing in the US and AstraZeneca authorized persons find scientifically balanced, evidence-based information about AstraZeneca drugs, submit a question, ask for field medical follow-up, and explore links to professional and patient support resources.

Are you a healthcare professional practicing in the United States?

I am an AstraZeneca authorized person   What is an AstraZeneca authorized person?This website is only intended for healthcare professionals practicing in the United States and authorized AstraZeneca personnel. AstraZeneca US Headquarters personnel and US Field Medical personnel are authorized to browse and search the database for their own background knowledge and insight. US Field Sales personnel should not access or browse this site. None of the content of this site should be directly linked or distributed without approval.
I am not a healthcare professional practicing in the United States (Take me to AstraZeneca.com)
AstraZeneca Logo
Pharma Logo

This site is intended for healthcare professionals practicing in the US.

©2025 AstraZeneca. All rights reserved.

US-69609; US-91816; US-103094; US-106788

Last Updated 11/25

Contact Us

About Us

AstraZeneca-US.com

Grant Opportunities

Survey Feedback

Your Privacy Choices

Consumer Health Data Privacy Notice

Privacy Notice

Legal Notice

Cookie Preferences

US Site

Global Site

Report Adverse Event or Product Quality Complaint

Survey Feedback

Your Privacy Choices

Consumer Health Data Privacy Notice

Pharma Logo

Privacy NoticeLegal NoticeCookie Preferences